Wall Street Associates’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $342K | Hold |
10,200
| – | – | 0.23% | 156 |
|
|
2016
Q3 | $271K | Hold |
10,200
| – | – | 0.09% | 201 |
|
|
2016
Q2 | $225K | Hold |
10,200
| – | – | 0.09% | 207 |
|
|
2016
Q1 | $300K | Hold |
10,200
| – | – | 0.12% | 183 |
|
|
2015
Q4 | $337K | Hold |
10,200
| – | – | 0.09% | 262 |
|
|
2015
Q3 | $369K | Sell |
10,200
-136,100
| -93% | -$4.92M | 0.07% | 253 |
|
|
2015
Q2 | $6.58M | Sell |
146,300
-5,500
| -4% | -$247K | 0.62% | 56 |
|
|
2015
Q1 | $4.65M | Sell |
151,800
-6,600
| -4% | -$202K | 0.44% | 82 |
|
|
2014
Q4 | $8.06M | Sell |
158,400
-700
| -0.4% | -$35.6K | 0.77% | 36 |
|
|
2014
Q3 | $6.3M | Sell |
159,100
-60,100
| -27% | -$2.38M | 0.65% | 50 |
|
|
2014
Q2 | $9.44M | Buy |
219,200
+2,600
| +1% | +$112K | 0.81% | 29 |
|
|
2014
Q1 | $8.66M | Sell |
216,600
-53,800
| -20% | -$2.15M | 0.71% | 43 |
|
|
2013
Q4 | $7.38M | Buy |
270,400
+15,500
| +6% | +$423K | 0.6% | 55 |
|
|
2013
Q3 | $5.84M | Sell |
254,900
-7,900
| -3% | -$181K | 0.54% | 60 |
|
|
2013
Q2 | $4.65M | Buy |
+262,800
| New | +$4.65M | 0.47% | 73 |
|